1 Result for "

LCB2122

" in MedChemExpress (MCE) Product Catalog:
Products (1)

1 Results for "LCB2122" in MCE Product Catalog:

Cat. No.: HY-180575
CAS No.: 2210298-14-7
LCB-2122 is an adenosine-like nucleoside analogue bearing a C2'-stereogenic all-carbon quaternary center. LCB-2122 can prevent Doxorubicin (HY-15142A)-induced cardiomyocytes apoptosis with an IC50 of 0.5 μM and prevent Imatinib (HY-15463)-induced apoptosis. LCB-2122 can activate AMPK signaling and induce the phosphorylation of AMPK and its downstream substrate, acetyl-CoA carboxylase (ACC). LCB-2122 can reduce Doxorubicin-induced mitochondrial damage. LCB-2122 can be used for the research of heart failure .
loading...
    loading...